These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2784156)

  • 21. Random assignment of treatments in a 96-well (8 X 12) microtiter plate. A practical method.
    Hooton JW; Paetkau V
    J Immunol Methods; 1986 Nov; 94(1-2):81-9. PubMed ID: 3491162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a new test for interleukin-2 assay.
    Patel R; Hajarian H; Patel DR
    J Immunol Methods; 1988 Sep; 112(2):285-6. PubMed ID: 3262140
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of an HTLV-I-infected human T-cell line (ATH8) in an interleukin-2 bioassay.
    Antonen J; Mitsuya H; Krohn K
    J Immunol Methods; 1987 May; 99(2):271-5. PubMed ID: 2884263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A convenient system for the serial quantitation of viable cells measuring luminescence of ATP.
    Scheirer W; Varecka R; Bachmayer H
    Dev Biol Stand; 1987; 66():349-55. PubMed ID: 3495462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-2 inhibitor and measurement of interleukin-2 in synovial fluid of patients with rheumatoid arthritis.
    Emery P; Mackay IR
    Arthritis Rheum; 1988 Dec; 31(12):1590-1. PubMed ID: 3264165
    [No Abstract]   [Full Text] [Related]  

  • 26. Persistence of anti-donor allohelper T cells after neonatal induction of allotolerance in mice.
    Abramowicz D; Vandervorst P; Bruyns C; Doutrelepont JM; Vandenabeele P; Goldman M
    Eur J Immunol; 1990 Aug; 20(8):1647-53. PubMed ID: 2145162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PROBIT: a computer program analysis.
    Wallis RS
    J Immunol Methods; 1991 Dec; 145(1-2):267-8. PubMed ID: 1765663
    [No Abstract]   [Full Text] [Related]  

  • 28. [Quantitative bioassay of human interleukin 1 and interleukin 2 activities].
    Shimizu S; Konda S
    Rinsho Byori; 1985 Apr; 33(4):365-70. PubMed ID: 3876458
    [No Abstract]   [Full Text] [Related]  

  • 29. Human interleukin 2.
    Robb RJ
    Methods Enzymol; 1985; 116():493-525. PubMed ID: 3937027
    [No Abstract]   [Full Text] [Related]  

  • 30. A new bioassay for the immunocytokine L19-IL2 for simultaneous analysis of both functional moieties.
    Winter J; Barbin K; Bacci C; Bunte T
    J Pharm Biomed Anal; 2011 Jan; 54(1):81-6. PubMed ID: 20828971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parameters for the evaluation of IL-2 stability.
    Kenney WC; Watson E; Bartley T; Boone T; Altrock BW
    Lymphokine Res; 1986; 5 Suppl 1():S23-7. PubMed ID: 3491260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Millipore diffusion chambers to assay in vivo IL-2 activity.
    Nishimura T; Uchiyama Y; Yagi H; Hashimoto Y
    J Immunol Methods; 1985 Apr; 78(2):239-45. PubMed ID: 3872915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human interleukin 2. Detection at the picomolar level by sandwich enzyme immunoassay.
    Ferrua B; Aussel C; Fehlmann M
    J Immunol Methods; 1987 Mar; 97(2):215-20. PubMed ID: 3493295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A convenient and reliable IL-2 bioassay using frozen CTLL-2 to improve the detection of helper T lymphocyte precursors.
    Weston L; Geczy A; Farrell C
    Immunol Cell Biol; 1998 Apr; 76(2):190-2. PubMed ID: 9619491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of OKT3 monoclonal antibodies and anti-TAC for the quantitative evaluation of interleukin-2].
    Cornaglia-Ferraris P; Baffico M
    Boll Ist Sieroter Milan; 1985; 64(6):471-4. PubMed ID: 3938289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The localization of lymphokines in murine germinal centers.
    Kasajima T; Andoh A; Takeo Y; Nishikawa T
    Adv Exp Med Biol; 1993; 329():371-6. PubMed ID: 8379397
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunoenzyme demonstration of human interleukin-2 denaturation and renaturation].
    Krüger-Rademann M; Mohr H; Brandt E
    Beitr Infusionther Klin Ernahr; 1987; 18():289-91. PubMed ID: 3326586
    [No Abstract]   [Full Text] [Related]  

  • 38. Bioassays for the detection of a cytokine that enhances the development of cytolytic T lymphocytes.
    Cernetti C; Steinman RM; Granelli-Piperno A
    Cell Immunol; 1987 Oct; 109(1):148-58. PubMed ID: 3308122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing CD4+ helper T-lymphocyte responses by lymphoproliferation.
    Quakyi IA; Ahlers JD
    Methods Mol Med; 2002; 72():369-83. PubMed ID: 12125133
    [No Abstract]   [Full Text] [Related]  

  • 40. IL-2 gene-modified tumour vaccines: monitoring of IL-2 levels in serum and peritoneal cavity of vaccinated mice.
    Indrová M; Pajtasz-Piasecka E; Jandlová T; Símová J; Bubeník J; Radzikowski C
    Folia Biol (Praha); 1999; 45(1):7-11. PubMed ID: 10732712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.